Ahsaini Mustapha, Omana Jean Paul, Mellas Soufiane, Ammari Jalal Eddine El, Tazi Mohammed Fadl, Fassi Mohammed Jamal El, Farih Moulay Hassan
Service d´Urologie, CHU Hassan II, Faculté de Médecine et de Pharmacie (USMBA), Fès, Maroc.
Pan Afr Med J. 2020 Oct 30;37:205. doi: 10.11604/pamj.2020.37.205.21774. eCollection 2020.
type 2 diabetes is a very common condition which, in some patients, may cause erectile dysfunction. The purpose of this study is to determine the prevalence and severity of erectile dysfunction in patients with type 2 diabetes attending the Department of Urology.
we conducted a cross-sectional and descriptive study in the Department of Urology at the University Hospital Center Hassan II in Fez using a self-administered questionnaire encompassing an "International Index of Erectile Function-5" test based on 5 questions with routine blood test results in diabetic patients.
a total of 96 anonymous questionnaires were distributed over a 12-month period. The average age of patients was 53.5 years, 35% (n=34) of them were active smokers. Diabetes had progressed for over 10 years in 54% (n=52) of cases. Three patients were treated with diet alone, 32% (n=31) with oral antidiabetic drugs, 31% (n=30) with insulin therapy alone and 31% (n=30) with insulin and oral antidiabetic drugs. Only 11% (n=11) of patients had HbA1c below 7%. Patients reporting erectile dysfunction accounted for 70% (n=67) of surveyed patients. The proportion of patients with erectile dysfunction according to the International Index of erectile function-5 was 88% (n=84). The onset of erectile dysfunction had started more than 3 years earlier in 63% (n=60) of patients. Disorders started progressively in 90% (n=86) of patients. Screening rate was 37.5% (n=36), only 30% (n=29) of patients received phosphodiesterase type 5 inhibitors, then intracavernous injection or both. Forty-two per cent (n=40) of patients had either macro or micro-angiopathic complications.
erectile dysfunction is a common but little suspected condition in diabetic men. Hence, the importance of systematic screening in any diabetic patient and of adequate treatment for sexual and cardiovascular disorders.
2型糖尿病是一种非常常见的疾病，在一些患者中可能会导致勃起功能障碍。本研究的目的是确定在泌尿外科就诊的2型糖尿病患者中勃起功能障碍的患病率和严重程度。
我们在非斯哈桑二世大学医院中心泌尿外科进行了一项横断面描述性研究，使用一份自填式问卷，其中包括基于5个问题的“国际勃起功能指数-5”测试以及糖尿病患者的常规血液检查结果。
在12个月的时间里共发放了96份匿名问卷。患者的平均年龄为53.5岁，其中35%（n = 34）为吸烟者。54%（n = 52）的病例中糖尿病病程超过10年。3名患者仅接受饮食治疗，32%（n = 31）使用口服降糖药，31%（n = 30）仅使用胰岛素治疗，31%（n = 30）使用胰岛素和口服降糖药。只有11%（n = 11）的患者糖化血红蛋白低于7%。报告有勃起功能障碍的患者占接受调查患者的70%（n = 67）。根据国际勃起功能指数-5，勃起功能障碍患者的比例为88%（n = 84）。63%（n = 60）的患者勃起功能障碍的发病始于3年多以前。90%（n = 86）的患者病情逐渐发展。筛查率为37.5%（n = 36），只有30%（n = 29）的患者接受了5型磷酸二酯酶抑制剂治疗，然后是海绵体内注射或两者兼用。42%（n = 40）的患者有大血管或微血管并发症。
勃起功能障碍在糖尿病男性中很常见，但很少被怀疑。因此，对任何糖尿病患者进行系统筛查以及对性和心血管疾病进行适当治疗非常重要。
